medroxyprogesterone acetate has been researched along with Adenocarcinoma, Endometrioid in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 15 (71.43) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Ascione, M; Bifulco, G; Boccia, D; Buonfantino, C; Cafasso, V; De Angelis, MC; Della Corte, L; Giampaolino, P; Grasso, G; Gullo, G; Mercorio, A; Palumbo, M; Serafino, P; Verrazzo, P; Viciglione, F | 1 |
| Cho, A; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, SW; Park, JY; Suh, DS | 1 |
| Li, L; Lin, J; Lou, H; Wang, F; Xu, H; Yu, A; Yu, H; Zhang, X | 1 |
| Bae, DS; Kang, SB; Kim, JW; Kim, MK; Kim, S; Lee, TS; Lim, MC; Nam, JH; Paek, J; Seong, SJ | 1 |
| Hamada, M; Hasegawa, K; Ito, K; Katoh, T; Kozawa, E; Shintani, D; Yano, M; Yasuda, M | 1 |
| Jun, HS; Kim, MK; Kim, ML; Kim, YS; Lee, YH; Seong, SJ; Song, T; Yoon, BS | 1 |
| Clarke, BA; Feigenberg, T; Ferguson, SE; Gien, LT; Ismiil, N; Laframboise, S; Massey, C; Simpson, AN | 1 |
| Aki, I; Fujita, M; Kimura, T; Kobayashi, E; Mabuchi, S; Ohyagi-Hara, C; Sawada, K; Tsutsui, T; Ueda, Y; Yoshino, K | 1 |
| Brady, WE; Duska, LR; Fischer, EG; Horowitz, NS; Ivanovic, M; Leslie, K; Mannel, RS; Todd, W; Walker, JL; Zaino, RJ | 1 |
| Kanao, H; Kondo, E; Matoda, M; Nomura, H; Sugiyama, Y; Takeshima, N; Tanigawa, T | 1 |
| Bai, Y; Gao, Y; Li, C; Li, M; Yan, L; Zhang, H; Zhang, L; Zhao, M; Zhao, X | 1 |
| Aoki, D; Banno, K; Hamatani, T; Hirasawa, A; Inoue, O; Kuji, N; Ogawa, S; Susumu, N; Takemoto, T; Tanaka, M; Yamagami, W | 1 |
| Franco, EL; Gotlieb, WH; Greenwald, ZR; Huang, LN; Wissing, MD | 1 |
| Hahn, HS; Hong, JS; Hong, SR; Kim, TJ; Kwon, YS; Lee, IH; Lee, KH; Lim, JY; Lim, KT; Mok, JE; Park, SJ; Shim, JU; Yoon, SG | 1 |
| Chung, HH; Kang, SB; Kim, JW; Kim, MK; Park, H; Seong, SJ; Yoon, BS | 1 |
| Kim, JY; Park, CT; Park, H; Seok, JM; Seong, SJ; Shim, JY; Yoon, BS | 1 |
| Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, KR; Kim, SM; Kim, TJ; Kim, YM; Kim, YT; Nam, JH; Park, JY; Seong, SJ | 1 |
| Bae, DS; Kim, JW; Kim, SM; Kim, TJ; Nam, JH; Park, JY; Seong, SJ | 1 |
| Akino, F; Hamano, M; Hashimura, M; Kuramoto, H; Kuwata, T; Okayasu, I; Saegusa, M; Watanabe, J; Yoshida, T | 1 |
| Baltar Arias, R; Castro Ortiz, E; Fernández Salgado, E; Ibáñez Pinto, A; Ledo Barro, L; Vázquez Astray, E; Vázquez San Luis, J; Vázquez Vázquez, S | 1 |
| Harashima, S; Hirashima, Y; Ito, I; Kawaguchi, R; Takahashi, N; Takekuma, M; Yamada, Y | 1 |
3 review(s) available for medroxyprogesterone acetate and Adenocarcinoma, Endometrioid
| Article | Year |
|---|---|
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Ki-67 Antigen; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; NF-E2-Related Factor 2; Pregnancy; Progestins; Survivin | 2022 |
Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Treatment Outcome; Young Adult | 2015 |
[Gastrointestinal bleeding of obscure origin caused by a metastatic endometrial adenocarcinoma. Response to hormonal therapy].
Topics: Aged; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Neoplasms; Female; Gastrointestinal Hemorrhage; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Pelvic Neoplasms; Peritoneal Neoplasms; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Umbilicus | 2007 |
3 trial(s) available for medroxyprogesterone acetate and Adenocarcinoma, Endometrioid
| Article | Year |
|---|---|
Six months response rate of combined oral medroxyprogesterone/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Biopsy, Needle; Carcinoma, Endometrioid; Dilatation and Curettage; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Prospective Studies | 2019 |
Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Middle Aged | 2014 |
Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women: pilot study.
Topics: Adult; Age Factors; Algorithms; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Endometrial Neoplasms; Feasibility Studies; Female; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Pilot Projects | 2011 |
15 other study(ies) available for medroxyprogesterone acetate and Adenocarcinoma, Endometrioid
| Article | Year |
|---|---|
Continued medical treatment for persistent early endometrial cancer in young women.
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy; Carcinoma, Endometrioid; Disease-Free Survival; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices; Levonorgestrel; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Myometrium; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome; Ultrasonography | 2021 |
Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma.
Topics: Adult; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Staging; Pregnancy; Retrospective Studies | 2017 |
Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Carcinoma, Endometrioid; Cell Differentiation; Endometrial Neoplasms; Endometrium; Female; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Mullerian Ducts; Retrospective Studies; Wolffian Ducts | 2019 |
Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Prospective Studies; Remission Induction; Treatment Outcome | 2013 |
Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Organ Sparing Treatments; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Reproductive Techniques, Assisted; Retrospective Studies; Treatment Outcome | 2014 |
Long-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate.
Topics: Adenomyoma; Adult; Aged; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Fertility Preservation; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Rate; Prognosis; Remission Induction; Retrospective Studies; Time Factors; Uterine Neoplasms | 2016 |
SPAG9 May Be a Potential Prognostic Marker of Endometrial Hyperplasia and Grade 1 Endometrioid Adenocarcinoma Treated with Progestin.
Topics: Adaptor Proteins, Signal Transducing; Adult; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Blotting, Western; Carcinoma, Endometrioid; Cell Line, Tumor; Early Detection of Cancer; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Medroxyprogesterone Acetate; Prognosis; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction | 2016 |
Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Infertility, Female; Logistic Models; Medroxyprogesterone Acetate; Multivariate Analysis; Odds Ratio; Pregnancy; Pregnancy Outcome; Recurrence; Retrospective Studies; Risk Factors | 2016 |
Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Cause of Death; Cohort Studies; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysterectomy; Kaplan-Meier Estimate; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Propensity Score; Proportional Hazards Models; SEER Program; Time Factors; United States | 2017 |
Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.
Topics: Adult; Algorithms; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Follow-Up Studies; Gynecologic Surgical Procedures; Humans; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progestins; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Contraceptives, Oral, Hormonal; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Maintenance Chemotherapy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Retrospective Studies; Time Factors; Uterine Neoplasms; Young Adult | 2012 |
Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).
Topics: Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Cohort Studies; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Survival Rate; Young Adult | 2013 |
Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Disease-Free Survival; Endometrial Neoplasms; Female; Fertility Agents; Humans; Infant, Newborn; Infertility, Female; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Neoplasm Staging; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Rate; Pregnancy, Ectopic; Premature Birth; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy.
Topics: Active Transport, Cell Nucleus; Adult; Amino Acid Substitution; Antineoplastic Agents, Hormonal; beta Catenin; Biomarkers; Carcinoma, Endometrioid; Cell Differentiation; Cell Nucleus; Cytoskeletal Proteins; Endometrial Neoplasms; Endometrium; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Hyperplasia; Luciferases; Medroxyprogesterone Acetate; Middle Aged; Mutation, Missense; Neoplasm Proteins; Point Mutation; Receptors, Progesterone; Recombinant Fusion Proteins; Trans-Activators; Transfection; Tumor Cells, Cultured | 2003 |
A patient with stage 1a endometrial carcinoma in whom a solitary recurrent lesion was detected in the external iliac lymph node after MPA therapy.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Positron-Emission Tomography; Sentinel Lymph Node Biopsy | 2008 |